Fred Hutch researchers move closer to cracking the code on how genes and environmental factors influence colorectal cancer risk
March 17, 2015
| By Diane Mapes / Fred Hutch News Service
A new study by public health researchers at Fred Hutchinson Cancer Research Center has discovered that the benefits of using aspirin and NSAIDs like ibuprofen to cut colorectal cancer risk actually hinge on a person’s particular DNA.
A new study identifies two genetic variants that may determine one’s risk for the disease
Oct. 24, 2013
| By Andy Koopmans
A new study suggests that interactions between one's genes and diet may be responsible for elevated risk of colorectal cancer in people who consume red and processed meats. The study also found a genetic variant associated with reduced colorectal cancer risk
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.